Quantitation of antibodies against SARS‐CoV‐2 spike protein after two doses of CoronaVac in healthcare workers
Author:
Affiliation:
1. Department of Medical Microbiology Sanko University School of Medicine Gaziantep Turkey
2. Department of Biostatistics Sanko University School of Medicine Gaziantep Turkey
Publisher
Wiley
Subject
Infectious Diseases,Virology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27098
Reference15 articles.
1. Development of an inactivated vaccine candidate for SARS-CoV-2
2. Clinical performance of different SARS‐CoV‐2 IgG antibody tests
3. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
4. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
5. SuhandynataRT BevinsNJ TranJT et al. SARS‐CoV‐2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses. medRxiv [Preprint].2021Mar 12:2021.03.10.21253299. doi:https://doi.org/10.1101/2021.03.10.21253299
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Protection Level of S-RBD SARS-CoV-2 Immunoglobulin G Antibodies Using the Chemiluminescent Immunoassay Compared to the Surrogate Virus Neutralization Test Method;Diagnostics;2024-08-14
2. Antibody Response after Homologous and Heterologous Prime–Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort;Vaccines;2024-04-30
3. İnaktif SARS-CoV-2 Aşısı Uygulanan Sağlık Çalışanlarında Anti-Spike S1 RBD IgG Değerlerinin Belirlenmesi;Black Sea Journal of Health Science;2024-03-01
4. The Long-Term Serological Profile of CoronaVac Vaccine Based on Comorbidities and History of SARS-CoV-2 Infection in Indonesia;Japanese Journal of Infectious Diseases;2024-01-31
5. Evaluation of antibody and T Cell immunity response in different immunization groups of inactive and mRNA COVID-19 vaccines;Diagnostic Microbiology and Infectious Disease;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3